LIVEBusiness & Money1 votes· 6h ago

When a big drug company buys a small biotech innovator, what usually happens to its treatments?

A major drugmaker is reportedly acquiring a startup developing psychedelic-based treatments for depression.

Grab this poll for your site

Votes cast anywhere this poll is embedded count toward the same live total.

<iframe src="https://groundbeat.com/embed/931" width="100%" height="420" frameborder="0" style="max-width:520px;border-radius:14px;"></iframe>
Sponsored

Discussion (0)

Be the first to weigh in.

More in Business & Money

When a big drug company buys a small biotech innovator, what usually happens to its treatments? — Groundbeat